429 related articles for article (PubMed ID: 25639873)
1. The tumor microenvironment shapes hallmarks of mature B-cell malignancies.
Shain KH; Dalton WS; Tao J
Oncogene; 2015 Sep; 34(36):4673-82. PubMed ID: 25639873
[TBL] [Abstract][Full Text] [Related]
2. Hematopoiesis in patients with mature B-cell malignancies is deregulated even in patients with undetectable bone marrow involvement.
Maswabi BC; Molinsky J; Savvulidi F; Zikmund T; Prukova D; Tuskova D; Klanova M; Vockova P; Lateckova L; Sefc L; Zivny J; Trneny M; Klener P
Haematologica; 2017 Apr; 102(4):e152-e155. PubMed ID: 28057744
[No Abstract] [Full Text] [Related]
3. Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy.
Dahl M; Kristensen LS; Grønbæk K
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134619
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment (TME)-driven immune suppression in B cell malignancy.
Nicholas NS; Apollonio B; Ramsay AG
Biochim Biophys Acta; 2016 Mar; 1863(3):471-482. PubMed ID: 26554850
[TBL] [Abstract][Full Text] [Related]
5. The Interplay between MicroRNAs and the Components of the Tumor Microenvironment in B-Cell Malignancies.
El-Daly SM; Bayraktar R; Anfossi S; Calin GA
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403283
[TBL] [Abstract][Full Text] [Related]
6. Premalignant cell dynamics in indolent B-cell malignancies.
Milpied P; Nadel B; Roulland S
Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal B cell lymphocytosis and "in situ" lymphoma.
Karube K; Scarfò L; Campo E; Ghia P
Semin Cancer Biol; 2014 Feb; 24():3-14. PubMed ID: 23999128
[TBL] [Abstract][Full Text] [Related]
8. Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients.
Arvidsson G; Henriksson J; Sander B; Wright AP
Haematologica; 2018 Apr; 103(4):666-678. PubMed ID: 29449436
[TBL] [Abstract][Full Text] [Related]
9. Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment.
Ghia P; Nadel B; Sander B; Stamatopoulos K; Stevenson FK
J Intern Med; 2017 Nov; 282(5):395-414. PubMed ID: 28393412
[TBL] [Abstract][Full Text] [Related]
10. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
11. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
Seda V; Mraz M
Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 expression in B-cell lymphomas.
Gladkikh A; Potashnikova D; Korneva E; Khudoleeva O; Vorobjev I
Exp Hematol; 2010 Nov; 38(11):1047-57. PubMed ID: 20727381
[TBL] [Abstract][Full Text] [Related]
13. BCL2 mutations in diffuse large B-cell lymphoma.
Schuetz JM; Johnson NA; Morin RD; Scott DW; Tan K; Ben-Nierah S; Boyle M; Slack GW; Marra MA; Connors JM; Brooks-Wilson AR; Gascoyne RD
Leukemia; 2012 Jun; 26(6):1383-90. PubMed ID: 22189900
[TBL] [Abstract][Full Text] [Related]
14. Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia.
Farfsing A; Engel F; Seiffert M; Hartmann E; Ott G; Rosenwald A; Stilgenbauer S; Döhner H; Boutros M; Lichter P; Pscherer A
Leukemia; 2009 Nov; 23(11):2018-26. PubMed ID: 19641524
[TBL] [Abstract][Full Text] [Related]
15. Targeting B-cell receptor signaling: changing the paradigm.
Fowler N; Davis E
Hematology Am Soc Hematol Educ Program; 2013; 2013():553-60. PubMed ID: 24319231
[TBL] [Abstract][Full Text] [Related]
16. Caught in transformation.
Xu ML; Cooper D
Blood; 2014 Oct; 124(17):2749. PubMed ID: 25513660
[No Abstract] [Full Text] [Related]
17. How the microenvironment wires the natural history of chronic lymphocytic leukemia.
Caligaris-Cappio F; Bertilaccio MT; Scielzo C
Semin Cancer Biol; 2014 Feb; 24():43-8. PubMed ID: 23831274
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Aurora-A and hMPS1 mitotic kinases in mantle cell lymphoma.
Camacho E; Beà S; Salaverría I; López-Guillermo A; Puig X; Benavente Y; de Sanjosé S; Campo E; Hernández L
Int J Cancer; 2006 Jan; 118(2):357-63. PubMed ID: 16080195
[TBL] [Abstract][Full Text] [Related]
19. Human B-cell cancer cell lines as a preclinical model for studies of drug effect in diffuse large B-cell lymphoma and multiple myeloma.
Laursen MB; Falgreen S; Bødker JS; Schmitz A; Kjeldsen MK; Sørensen S; Madsen J; El-Galaly TC; Bøgsted M; Dybkær K; Johnsen HE;
Exp Hematol; 2014 Nov; 42(11):927-38. PubMed ID: 25072621
[TBL] [Abstract][Full Text] [Related]
20. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
